AAAAAA

   
Results: 1-15 |
Results: 15
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial
Authors: Furst, DE Clements, PJ Wong, WK Mayes, MD Wigley, F White, B Weisman, M Barr, W Moreland, L Martin, R Medsger, TA Steen, V Collier, D Weinstein, A Lally, E Varga, J Weiner, SR Andrews, B Abeles, M Peter, JB Seibold, JR
Citation: De. Furst et al., Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial, RHEUMATOLOG, 40(6), 2001, pp. 615-622
Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenon
Authors: Furspan, PB Mayes, MD Freedman, RR
Citation: Pb. Furspan et al., Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenon, J RHEUMATOL, 28(10), 2001, pp. 2263-2268
Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma
Authors: Freedman, RR Girgis, R Mayes, MD
Citation: Rr. Freedman et al., Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma, J RHEUMATOL, 28(1), 2001, pp. 119-121
Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts
Authors: Arnett, FC Cho, M Chatterjee, S Aguilar, MB Reveille, JD Mayes, MD
Citation: Fc. Arnett et al., Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts, ARTH RHEUM, 44(6), 2001, pp. 1359-1362
Potential risk factors for undifferentiated connective tissue disease among women: Implanted medical devices
Authors: Laing, TJ Schottenfeld, D Lacey, JV Gillespie, BW Garabrant, DH Cooper, BC Heeringa, SG Alcser, KH Mayes, MD
Citation: Tj. Laing et al., Potential risk factors for undifferentiated connective tissue disease among women: Implanted medical devices, AM J EPIDEM, 154(7), 2001, pp. 610-617
Photopheresis and autoimmune diseases
Authors: Mayes, MD
Citation: Md. Mayes, Photopheresis and autoimmune diseases, RHEUM DIS C, 26(1), 2000, pp. 75
Approaches for identifying and defining environmentally associated rheumatic disorders
Authors: Miller, FW Hess, EV Clauw, DJ Hertzman, PA Pincus, T Silver, RM Mayes, MD Varga, J Medsger, TA Love, LA
Citation: Fw. Miller et al., Approaches for identifying and defining environmentally associated rheumatic disorders, ARTH RHEUM, 43(2), 2000, pp. 243-249
Comparison of sustained-release nifedipine and temperature biofeedback fortreatment of primary Raynaud phenomenon - Results from a randomized clinical trial with 1-year follow-up
Authors: Wigley, FM Wise, R Haythornthwaite, J Rand, C Smith, EA Maricq, HR Middaugh, S Silver, RM Valter, I Allenback, G Arnold, J Steedman, S Risinger, A King, A Bielory, L Attanasio, V Tarantola, J Centeno, L Jacob, RG Medsger, T Jennings, R Scheier, M Vaughan, C Wasko, MC Steen, VD Dunbar-Jacob, J Tamres, L Freedman, RR Mayes, MD Brejnak, C Tindall, C Bielory, L Thompson, B Frederick, M Canner, M Canner, J Canner, P Shaffer, TR Hill, DR Kaufmann, PG Czajkowski, S Geller, N Hunsberger, S Jennings, C Stevens, WM Hess, EV Corson, JA Jobe, JB Smith, H Tilley, B
Citation: Fm. Wigley et al., Comparison of sustained-release nifedipine and temperature biofeedback fortreatment of primary Raynaud phenomenon - Results from a randomized clinical trial with 1-year follow-up, ARCH IN MED, 160(8), 2000, pp. 1101-1108
Recombinant human relaxin in the treatment of scleroderma - A randomized, double-blind, placebo-controlled trial
Authors: Seibold, JR Korn, JH Simms, R Clements, PJ Moreland, LW Mayes, MD Furst, DE Rothfield, N Steen, V Weisman, M Collier, D Wigley, FM Merkel, PA Csuka, ME Hsu, V Rocco, S Erikson, M Hannigan, J Harkonen, WS Sanders, ME
Citation: Jr. Seibold et al., Recombinant human relaxin in the treatment of scleroderma - A randomized, double-blind, placebo-controlled trial, ANN INT MED, 132(11), 2000, pp. 871
Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma
Authors: Freedman, RR Girgis, R Mayes, MD
Citation: Rr. Freedman et al., Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma, J RHEUMATOL, 26(11), 1999, pp. 2386-2388
Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma
Authors: Freedman, RR Girgis, R Mayes, MD
Citation: Rr. Freedman et al., Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma, LANCET, 354(9180), 1999, pp. 739-739
Epidemiologic studies of environmental agents and systemic autoimmune diseases
Authors: Mayes, MD
Citation: Md. Mayes, Epidemiologic studies of environmental agents and systemic autoimmune diseases, ENVIR H PER, 107, 1999, pp. 743-748
IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced celldeath
Authors: Kirk, TZ Mayes, MD
Citation: Tz. Kirk et Md. Mayes, IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced celldeath, BIOC BIOP R, 255(1), 1999, pp. 129-132
Petroleum distillate solvents as risk factors for Undifferentiated Connective Tissue Disease (UCTD)
Authors: Lacey, JV Garabrant, DH Laing, TJ Gillespie, BW Mayes, MD Cooper, BC Schottenfeld, D
Citation: Jv. Lacey et al., Petroleum distillate solvents as risk factors for Undifferentiated Connective Tissue Disease (UCTD), AM J EPIDEM, 149(8), 1999, pp. 761-770
Maternal scleroderma: Placental findings and perinatal outcome
Authors: Doss, BJ Jacques, SM Mayes, MD Qureshi, F
Citation: Bj. Doss et al., Maternal scleroderma: Placental findings and perinatal outcome, HUMAN PATH, 29(12), 1998, pp. 1524-1530
Risultati: 1-15 |